Neurotoxicity with high-dose disulfiram and vorinostat used for hiv latency reversal

Author(s):

James H. Mcmahon, Vanessa A. Evans, Jillian S.Y. Lau, Jori Symons, Jennifer M. Zerbato, Judy Chang, Ajantha Solomon, Surekha Tennakoon, Ashanti Dantanarayana, Michelle Hagenauer, Sulggi Lee, Sarah Palmer, Katie Fisher, Namandje Bumpus, Carley J.S. Heck, David Burger, Guoxin Wu, Paul Zuck, Bonnie J. Howell, Henrik H. Zetterberg, Kaj Blennow, Magnus Gisslen, Thomas A. Rasmussen, Sharon R. Lewin

Details:

AIDS, Volume 36, Issue 1, 2022-01-01

Article Link: Click here

Affiliations:

• Sahlgrenska Universitetssjukhuset
• Sahlgrenska Akademin
• University of Melbourne
• The University of Sydney
• University of California, San Francisco
• University College London
• UCL Queen Square Institute of Neurology
• Göteborgs Universitet
• The Alfred
• Merck & Co., Inc.
• Johns Hopkins University
• Royal Melbourne Hospital
• Radboud University Medical Center